Home/ Stocks/ SRPT

Sarepta Therapeutics,, Inc. Common Stock

SRPT XNAS

$18.88 -0.09 (-0.47%) ▼ 15-min delayed

Open

$18.39

High

$18.94

Low

$18.15

Volume

1.49M

Market Cap

$1.98B

About Sarepta Therapeutics,, Inc. Common Stock

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1.4K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$399.36M	$-179,947,000	$-1.80
Q2 2025	$611.09M	$196.89M	$2.01
Q1 2025	$744.86M	$-447,508,000	$-4.60
FY 2024	$1.90B	$235.24M	$2.47

Ticker Daily Articles on SRPT

OTC vs Listed Penny Stocks: Where to Trade (and Where to Avoid)

Marcus Rivera · 3h ago · News

Get SRPT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sarepta Therapeutics,, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.